| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CRONCronos Group Inc. | 991.69M | 2.59 | 23.55 | 34.82% | 27.27% | 3.19% | 0.57% | 0.00 |
| CGCCanopy Growth Corporation | 460.99M | 1.22 | -0.22 | -9.47% | -138.49% | -52.42% | 0.72 | |
| SNDLSNDL Inc. | 417.15M | 1.62 | -4.30 | 1.26% | -9.7% | -8.39% | 10.52% | 0.13 |
| OGIOrganigram Global Inc. | 213.79M | 1.59 | -11.36 | 16.42% | -13.3% | -9.88% | 0.03 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 12.7M | 39.9M | 77.95M | 226.34M | 398.77M | 546.65M | 475.7M | 333.25M | 297.15M | 269M |
| Revenue Growth % | 10.08% | 2.14% | 0.95% | 1.9% | 0.76% | 0.37% | -0.13% | -0.3% | -0.11% | -0.09% |
| Cost of Goods Sold | -6.29M | 2.26M | 3.76M | 137.41M | 430.46M | 479.69M | 663.11M | 396.78M | 216.26M | 189.48M |
| COGS % of Revenue | -0.5% | 0.06% | 0.05% | 0.61% | 1.08% | 0.88% | 1.39% | 1.19% | 0.73% | 0.7% |
| Gross Profit | 18.99M | 37.63M | 74.19M | 88.93M | -31.68M | 66.96M | -187.41M | -63.53M | 80.88M | 79.51M |
| Gross Margin % | 1.5% | 0.94% | 0.95% | 0.39% | -0.08% | 0.12% | -0.39% | -0.19% | 0.27% | 0.3% |
| Gross Profit Growth % | 44.82% | 0.98% | 0.97% | 0.2% | -1.36% | 3.11% | -3.8% | 0.66% | 2.27% | -0.02% |
| Operating Expenses | 20.3M | 45.43M | 153.07M | 642.58M | 1.64B | 1.31B | 831.38M | 2.57B | 309.6M | 196.65M |
| OpEx % of Revenue | 1.6% | 1.14% | 1.96% | 2.84% | 4.11% | 2.4% | 1.75% | 7.7% | 1.04% | 0.73% |
| Selling, General & Admin | 17.33M | 38.55M | 131.13M | 605.83M | 867.74M | 523.85M | 361.1M | 297.98M | 180.59M | 121.71M |
| SG&A % of Revenue | 1.36% | 0.97% | 1.68% | 2.68% | 2.18% | 0.96% | 0.76% | 0.89% | 0.61% | 0.45% |
| Research & Development | 721K | 810K | 1.45M | 15.24M | 61.81M | 57.58M | 32.26M | 21.72M | 4.61M | 0 |
| R&D % of Revenue | 0.06% | 0.02% | 0.02% | 0.07% | 0.16% | 0.11% | 0.07% | 0.07% | 0.02% | - |
| Other Operating Expenses | 2.26M | -585K | 20.49M | 21.51M | 707.73M | 728.99M | 438.03M | 2.25B | 124.39M | 74.95M |
| Operating Income | -2.75M | -15.21M | -78.88M | -553.64M | -1.67B | -1.24B | -1.02B | -2.63B | -228.71M | -117.14M |
| Operating Margin % | -0.22% | -0.38% | -1.01% | -2.45% | -4.19% | -2.27% | -2.14% | -7.89% | -0.77% | -0.44% |
| Operating Income Growth % | 0.64% | -4.53% | -4.18% | -6.02% | -2.01% | 0.25% | 0.18% | -1.58% | 0.91% | 0.49% |
| EBITDA | -493K | -9.15M | -58.39M | -506.73M | -1.54B | -1.12B | -907.86M | -2.55B | -175.54M | -74.03M |
| EBITDA Margin % | -0.04% | -0.23% | -0.75% | -2.24% | -3.87% | -2.04% | -1.91% | -7.65% | -0.59% | -0.28% |
| EBITDA Growth % | 0.93% | -17.56% | -5.38% | -7.68% | -2.05% | 0.28% | 0.19% | -1.81% | 0.93% | 0.58% |
| D&A (Non-Cash Add-back) | 2.26M | 6.06M | 20.49M | 46.92M | 125.01M | 127.12M | 110.94M | 80.03M | 53.18M | 43.12M |
| EBIT | -1.32M | -6.71M | -50.67M | -689.5M | -1.5B | -576.77M | -163.92M | -2.96B | -366M | -522.43M |
| Net Interest Income | -140K | -66K | 566K | 30.9M | 59.61M | 12.91M | -97.34M | -101.88M | -89.12M | -65.38M |
| Interest Income | 0 | 0 | 1.35M | 49.31M | 66.33M | 21.37M | 6.6M | 24.28M | 16.23M | 8.76M |
| Interest Expense | 140K | 66K | 784K | 18.41M | 6.72M | 8.46M | 103.94M | 126.16M | 105.35M | 74.14M |
| Other Income/Expense | -621K | 3.81M | 68.53M | -59.71M | 159.91M | -440.5M | 750.94M | -455.64M | -242.64M | -479.85M |
| Pretax Income | -3.37M | -17.06M | -52.54M | -657.78M | -1.51B | -1.68B | -267.86M | -3.09B | -471.36M | -597M |
| Pretax Margin % | -0.27% | -0.43% | -0.67% | -2.91% | -3.78% | -3.08% | -0.56% | -9.26% | -1.59% | -2.22% |
| Income Tax | 126K | -401K | -1.59M | 12.32M | -121.61M | -13.14M | -8.95M | -5.73M | 12.33M | 7.14M |
| Effective Tax Rate % | 1.04% | 0.97% | 1.03% | 1.02% | 0.88% | 1.04% | 1.16% | 1.06% | 1.39% | 1% |
| Net Income | -3.5M | -16.61M | -54.13M | -670.09M | -1.32B | -1.74B | -310.04M | -3.28B | -657.27M | -598.12M |
| Net Margin % | -0.28% | -0.42% | -0.69% | -2.96% | -3.31% | -3.19% | -0.65% | -9.84% | -2.21% | -2.22% |
| Net Income Growth % | 0.61% | -3.75% | -2.26% | -11.38% | -0.97% | -0.32% | 0.82% | -9.57% | 0.8% | 0.09% |
| Net Income (Continuing) | -3.5M | -7.57M | -51.06M | -712.02M | -1.39B | -1.67B | -258.91M | -3.08B | -483.68M | -604.14M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | -71.66M | -229.12M | -192.11M | 6.02M |
| Minority Interest | 0 | -32K | 84.47M | 289.81M | 204.8M | 140.01M | 36.84M | 1.59M | 139K | 0 |
| EPS (Diluted) | -0.05 | -0.14 | -0.31 | -1.99 | -3.90 | -4.45 | -7.70 | -70.70 | -8.79 | -5.53 |
| EPS Growth % | 0.85% | -2.08% | -1.21% | -5.42% | -0.96% | -0.14% | -0.73% | -8.18% | 0.88% | 0.37% |
| EPS (Basic) | -0.05 | -0.14 | -0.31 | -1.99 | -3.96 | -4.45 | -7.70 | -70.70 | -6.47 | -5.53 |
| Diluted Shares Outstanding | 77.02M | 118.99M | 177.3M | 337.51M | 356.15M | 375.71M | 39.13M | 46.37M | 74.79M | 107.55M |
| Basic Shares Outstanding | 77.02M | 118.99M | 177.3M | 337.51M | 350.03M | 375.28M | 39.13M | 46.37M | 101.63M | 107.55M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 44.85M | 177.7M | 481.78M | 5.07B | 1.8B | 2.84B | 1.73B | 1.08B | 371.18M | 294.57M |
| Cash & Short-Term Investments | 15.4M | 101.8M | 322.56M | 4.51B | 1.4B | 2.32B | 1.37B | 773.22M | 203.46M | 131.47M |
| Cash Only | 15.4M | 101.8M | 322.56M | 2.48B | 915.57M | 1.15B | 776M | 667.69M | 170.3M | 113.81M |
| Short-Term Investments | 0 | 0 | 0 | 2.03B | 488.19M | 1.16B | 595.65M | 105.53M | 33.16M | 17.66M |
| Accounts Receivable | 1.49M | 5.82M | 21.43M | 106.97M | 63.34M | 67.11M | 86.58M | 68.46M | 44.94M | 52.78M |
| Days Sales Outstanding | 42.71 | 53.2 | 100.32 | 172.51 | 57.98 | 44.81 | 66.43 | 74.98 | 55.21 | 71.62 |
| Inventory | 22.15M | 45.98M | 101.61M | 262.11M | 274.76M | 369.48M | 204.54M | 83.23M | 77.29M | 96.37M |
| Days Inventory Outstanding | -1.29K | 7.42K | 9.87K | 696.22 | 232.98 | 281.14 | 112.59 | 76.56 | 130.45 | 185.64 |
| Other Current Assets | 5.32M | 22.26M | 842K | 38.48M | 15.78M | 55.73M | 31.28M | 138.17M | 35.74M | 8.44M |
| Total Non-Current Assets | 98.52M | 499.9M | 955.04M | 3.66B | 3.02B | 3.99B | 3.88B | 1.36B | 929.15M | 623.13M |
| Property, Plant & Equipment | 44.98M | 96.27M | 303.68M | 1.1B | 1.07B | 1.07B | 942.78M | 471.27M | 320.1M | 293.52M |
| Fixed Asset Turnover | 0.28x | 0.41x | 0.26x | 0.21x | 0.37x | 0.51x | 0.50x | 0.71x | 0.93x | 0.92x |
| Goodwill | 20.87M | 241.37M | 314.92M | 1.54B | 1.37B | 1.89B | 1.87B | 85.56M | 43.24M | 46.04M |
| Intangible Assets | 31.86M | 162.26M | 101.53M | 519.56M | 334.68M | 308.17M | 252.69M | 160.75M | 104.05M | 87.2M |
| Long-Term Investments | 246K | 24.03M | 226.57M | 475.81M | 221.38M | 610.74M | 341.73M | 568.29M | 136.22M | 35.29M |
| Other Non-Current Assets | -1.83M | -52.01M | -32.16M | -20.62M | 13.13M | 102.49M | 473.94M | 76.56M | 325.53M | 161.07M |
| Total Assets | 143.36M | 677.61M | 1.44B | 8.73B | 4.82B | 6.82B | 5.61B | 2.44B | 1.3B | 917.7M |
| Asset Turnover | 0.09x | 0.06x | 0.05x | 0.03x | 0.08x | 0.08x | 0.08x | 0.14x | 0.23x | 0.29x |
| Asset Growth % | 2% | 3.73% | 1.12% | 5.08% | -0.45% | 0.42% | -0.18% | -0.56% | -0.47% | -0.29% |
| Total Current Liabilities | 7.19M | 17.66M | 92.03M | 411.66M | 295.49M | 284.33M | 213.19M | 803.84M | 234.72M | 94.4M |
| Accounts Payable | 5.86M | 5.66M | 46.17M | 188.92M | 86.69M | 67.26M | 64.27M | 31.84M | 28.67M | 26.1M |
| Days Payables Outstanding | -340.04 | 913.06 | 4.49K | 501.82 | 73.51 | 51.18 | 35.38 | 29.29 | 48.39 | 50.27 |
| Short-Term Debt | 553K | 1.69M | 1.56M | 103.72M | 39.87M | 9.83M | 9.3M | 556.89M | 103.94M | 4.26M |
| Deferred Revenue (Current) | 533K | 588K | 900K | 1000K | 0 | 0 | 0 | 0 | 1000K | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 98.45M | 145.45M | 106.4M | 76.71M | 175M | 53.77M | 31.73M |
| Current Ratio | 6.23x | 10.06x | 5.24x | 12.32x | 6.10x | 9.98x | 8.10x | 1.34x | 1.58x | 3.12x |
| Quick Ratio | 3.15x | 7.46x | 4.13x | 11.68x | 5.17x | 8.68x | 7.14x | 1.24x | 1.25x | 2.10x |
| Cash Conversion Cycle | -903.37 | 6.56K | 5.49K | 366.91 | 217.45 | 274.76 | 143.64 | 122.26 | 137.26 | 206.99 |
| Total Non-Current Liabilities | 12.38M | 45.2M | 101.55M | 1.08B | 884.73M | 2.92B | 1.77B | 875.83M | 565.11M | 336.08M |
| Long-Term Debt | 3.47M | 8.64M | 6.87M | 842.26M | 315.47M | 1.57B | 1.49B | 749.99M | 493.29M | 299.81M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 84.34M | 94.16M | 101.13M | 78.37M | 55.6M | 27.79M |
| Deferred Tax Liabilities | 7.41M | 35.8M | 33.54M | 96.03M | 33.1M | 0 | 15.99M | 357K | 0 | 0 |
| Other Non-Current Liabilities | 1.5M | 36.56M | 61.15M | 239.09M | 451.82M | 1.25B | 162.84M | 47.12M | 16.22M | 8.49M |
| Total Liabilities | 19.58M | 62.87M | 193.58M | 1.49B | 1.18B | 3.2B | 1.98B | 1.68B | 799.82M | 430.49M |
| Total Debt | 4.02M | 10.33M | 8.42M | 945.98M | 439.68M | 1.72B | 1.64B | 1.41B | 668M | 348.4M |
| Net Debt | -11.38M | -91.47M | -314.14M | -1.53B | -475.89M | 564.53M | 864.15M | 745.98M | 497.7M | 234.59M |
| Debt / Equity | 0.03x | 0.02x | 0.01x | 0.13x | 0.12x | 0.47x | 0.45x | 1.86x | 1.33x | 0.72x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -19.64x | -230.53x | -100.61x | -30.06x | -248.51x | -147.00x | -9.80x | -20.85x | -2.17x | -1.58x |
| Total Equity | 123.78M | 614.74M | 1.24B | 7.24B | 3.64B | 3.62B | 3.62B | 760.02M | 500.51M | 487.21M |
| Equity Growth % | 1.99% | 3.97% | 1.02% | 4.82% | -0.5% | -0% | -0% | -0.79% | -0.34% | -0.03% |
| Book Value per Share | 1.61 | 5.17 | 7.01 | 21.46 | 10.21 | 9.64 | 92.52 | 16.39 | 6.69 | 4.53 |
| Total Shareholders' Equity | 123.78M | 614.77M | 1.16B | 6.95B | 3.43B | 3.48B | 3.58B | 758.43M | 500.37M | 487.21M |
| Common Stock | 131.08M | 621.54M | 1.08B | 6.03B | 4.48B | 7.17B | 7.48B | 7.94B | 8.24B | 8.8B |
| Retained Earnings | -13.78M | -30.38M | -91.65M | -777.09M | -3.04B | -6.07B | -6.38B | -9.67B | -10.33B | -10.93B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 5.8M | 23.61M | 173.58M | 1.7B | 155.2M | -34.24M | -42.28M | -13.86M | -16.05M | 535K |
| Minority Interest | 0 | -32K | 84.47M | 289.81M | 204.8M | 140.01M | 36.84M | 1.59M | 139K | 0 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -12.45M | -27.09M | -81.51M | -520.51M | -772.63M | -465.73M | -545.81M | -557.55M | -281.95M | -165.75M |
| Operating CF Margin % | -0.98% | -0.68% | -1.05% | -2.3% | -1.94% | -0.85% | -1.15% | -1.67% | -0.95% | -0.62% |
| Operating CF Growth % | -0.28% | -1.18% | -2.01% | -5.39% | -0.48% | 0.4% | -0.17% | -0.02% | 0.49% | 0.41% |
| Net Income | -3.5M | -16.66M | -54.13M | -670.09M | -1.39B | -1.67B | -258.91M | -3.08B | -483.68M | -604.14M |
| Depreciation & Amortization | 2.26M | 6.06M | 20.49M | 46.92M | 125.01M | 127.12M | 110.94M | 80.03M | 53.18M | 43.12M |
| Stock-Based Compensation | 3.68M | 10.04M | 51.18M | 287.78M | 320.28M | 91.15M | 46.69M | 25.32M | 14.18M | -4.21M |
| Deferred Taxes | 126K | -401K | 1.59M | 12.32M | -121.61M | -13.14M | -8.95M | -5.73M | 12.33M | 7.14M |
| Other Non-Cash Items | -37.7M | -22.06M | -72.11M | 64.73M | 342.24M | 972.23M | -640.58M | 2.36B | 118.08M | 424.3M |
| Working Capital Changes | 22.69M | -4.08M | -28.52M | -262.17M | -51.11M | 27.73M | 205M | 58.97M | 3.97M | -31.96M |
| Change in Receivables | -299K | -2.18M | -15.74M | -67.69M | 20.98M | -11.99M | 16.15M | 6.24M | -3.75M | -4.49M |
| Change in Inventory | 20.06M | 34.76M | -24.49M | -144.92M | -33.95M | 23.11M | 204.22M | 68.44M | 1.03M | -17.71M |
| Change in Payables | 2.39M | -200K | 11.4M | 69.54M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -12.3M | -18.6M | -223.58M | -3.23B | -347.65M | -884.11M | 230.82M | 433.38M | 241.59M | -47.79M |
| Capital Expenditures | -10.71M | -29.53M | -178.17M | -682.75M | -704.94M | -164.5M | -36.68M | -9.11M | -3.45M | -10.81M |
| CapEx % of Revenue | 0.84% | 0.74% | 2.29% | 3.02% | 1.77% | 0.3% | 0.08% | 0.03% | 0.01% | 0.04% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -2.41M | 178K | -13.31M | -53.05M | -41.44M | -172.2M | -2.29M | -7.88M | 167.79M | 48.9M |
| Cash from Financing | 18.7M | 132.1M | 525.85M | 5.84B | -57.16M | 1.26B | -45.53M | -19.69M | -465.06M | 148.66M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 6.38M | -979K | 1.81M | 28.92M | 43.03M | 387.23M | 2.53M | -37.72M | -36.34M | -15.96M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -23.16M | -56.63M | -259.68M | -1.2B | -1.49B | -639.87M | -593.92M | -568M | -285.95M | -177.03M |
| FCF Margin % | -1.82% | -1.42% | -3.33% | -5.32% | -3.75% | -1.17% | -1.25% | -1.7% | -0.96% | -0.66% |
| FCF Growth % | -0.07% | -1.44% | -3.59% | -3.63% | -0.24% | 0.57% | 0.07% | 0.04% | 0.5% | 0.38% |
| FCF per Share | -0.30 | -0.48 | -1.46 | -3.57 | -4.20 | -1.70 | -15.18 | -12.25 | -3.82 | -1.65 |
| FCF Conversion (FCF/Net Income) | 3.56x | 1.63x | 1.51x | 0.78x | 0.58x | 0.27x | 1.76x | 0.17x | 0.43x | 0.28x |
| Interest Paid | 0 | 0 | 0 | 0 | 25.47M | 25.65M | 119.25M | 131.82M | 98.12M | 64.9M |
| Taxes Paid | 0 | 0 | 0 | 502K | 5.46M | 22.77M | 2.64M | 1.18M | 2.08M | 783K |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -4.23% | -4.5% | -5.83% | -15.8% | -24.29% | -48.07% | -8.56% | -149.67% | -104.28% | -121.11% |
| Return on Invested Capital (ROIC) | -3.07% | -3.59% | -8.15% | -12.52% | -28.23% | -25.38% | -17.62% | -65.87% | -13.7% | -10.22% |
| Gross Margin | 149.51% | 94.33% | 95.18% | 39.29% | -7.95% | 12.25% | -39.4% | -19.06% | 27.22% | 29.56% |
| Net Margin | -27.53% | -41.63% | -69.45% | -296.06% | -331.35% | -319.2% | -65.18% | -983.68% | -221.19% | -222.35% |
| Debt / Equity | 0.03x | 0.02x | 0.01x | 0.13x | 0.12x | 0.47x | 0.45x | 1.86x | 1.33x | 0.72x |
| Interest Coverage | -19.64x | -230.53x | -100.61x | -30.06x | -248.51x | -147.00x | -9.80x | -20.85x | -2.17x | -1.58x |
| FCF Conversion | 3.56x | 1.63x | 1.51x | 0.78x | 0.58x | 0.27x | 1.76x | 0.17x | 0.43x | 0.28x |
| Revenue Growth | 1008.44% | 214.16% | 95.38% | 190.37% | 76.18% | 37.08% | -12.98% | -29.94% | -10.83% | -9.47% |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Canadian Cannabis Net Revenue | - | - | - | 285.05M | 257.91M | - | - | 155.86M |
| Canadian Cannabis Net Revenue Growth | - | - | - | - | -9.52% | - | - | - |
| Storz And Bickel | - | - | - | - | - | - | - | 73.4M |
| Storz And Bickel Growth | - | - | - | - | - | - | - | - |
| International And Other Revenue | - | - | - | 62.34M | 36.11M | - | - | 39.73M |
| International And Other Revenue Growth | - | - | - | - | -42.07% | - | - | - |
| Other Revenue | - | - | 105.5M | - | - | 16.36M | 10.19M | - |
| Other Revenue Growth | - | - | - | - | - | - | -37.72% | - |
| Global Cannabis Net Revenue | - | - | - | 378.68M | 337.22M | - | - | - |
| Global Cannabis Net Revenue Growth | - | - | - | - | -10.95% | - | - | - |
| Canadian Recreational Cannabis Net Revenue | - | - | - | 229.6M | 205.3M | - | - | - |
| Canadian Recreational Cannabis Net Revenue Growth | - | - | - | - | -10.58% | - | - | - |
| Consumer Products And Other | - | - | - | 167.97M | 183.11M | - | - | - |
| Consumer Products And Other Growth | - | - | - | - | 9.01% | - | - | - |
| Canadian Medical Cannabis Net Revenue | - | - | - | 55.45M | 52.61M | - | - | - |
| Canadian Medical Cannabis Net Revenue Growth | - | - | - | - | -5.12% | - | - | - |
| Medical Cannabis Revenue | - | - | 67.97M | - | - | - | - | - |
| Medical Cannabis Revenue Growth | - | - | - | - | - | - | - | - |
| Recreational Revenue | - | - | 52.04M | - | - | - | - | - |
| Recreational Revenue Growth | - | - | - | - | - | - | - | - |
| Medical Cannabis | - | 27.86M | - | - | - | - | - | - |
| Medical Cannabis Growth | - | - | - | - | - | - | - | - |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Canadian Cannabis Net Revenue | - | - | - | - | - | - | - | 155.86M |
| Canadian Cannabis Net Revenue Growth | - | - | - | - | - | - | - | - |
| Storz And Bickel | - | - | - | - | - | - | - | 73.4M |
| Storz And Bickel Growth | - | - | - | - | - | - | - | - |
| International And Other Revenue | - | - | - | - | - | - | - | 39.73M |
| International And Other Revenue Growth | - | - | - | - | - | - | - | - |
| Other Revenue | - | - | - | - | - | - | - | - |
| Other Revenue Growth | - | - | - | - | - | - | - | - |
| GERMANY | - | - | - | 116.38M | 90.87M | - | 52.19M | - |
| GERMANY Growth | - | - | - | - | -21.92% | - | - | - |
| Other Geographical Area | - | - | - | 36.17M | 51M | - | 41.25M | - |
| Other Geographical Area Growth | - | - | - | - | 41.00% | - | - | - |
| UNITED STATES | - | - | - | 64.93M | 82.08M | - | 40.99M | - |
| UNITED STATES Growth | - | - | - | - | 26.42% | - | - | - |
| CANADA | - | - | - | - | - | 268.46M | - | - |
| CANADA Growth | - | - | - | - | - | - | - | - |
| Non Canada | - | - | 142.61M | - | - | - | - | - |
| Non Canada Growth | - | - | - | - | - | - | - | - |
| Foreign Countries | 3.75M | - | - | - | - | - | - | - |
| Foreign Countries Growth | - | - | - | - | - | - | - | - |
Canopy Growth Corporation (CGC) reported $278.6M in revenue for fiscal year 2024.
Canopy Growth Corporation (CGC) saw revenue decline by 9.5% over the past year.
Canopy Growth Corporation (CGC) reported a net loss of $385.9M for fiscal year 2024.
Canopy Growth Corporation (CGC) has a return on equity (ROE) of -121.1%. Negative ROE indicates the company is unprofitable.
Canopy Growth Corporation (CGC) had negative free cash flow of $96.1M in fiscal year 2024, likely due to heavy capital investments.